Table 2.
Visual analog pain score (0–100 mm)a | 150 mcg PF-morphine + placebo (control group, n = 30) | 300 mcg PF-morphine + acetaminophen (intervention group, n = 30) | P value |
---|---|---|---|
Movement at 24 hours,b mean ± SD (mm) | 46 ± 25 | 31 ± 17 | 0.009 |
Resting at 24 hours, median [IQR] (mm) | 19 (0–33) | 4 (0–10) | 0.011 |
Average over 24 hours, mean ± SD (mm) | 37 ± 19 | 23 ± 14 | 0.002 |
Worst over 24 hours, median [IQR] (mm) | 69 (49–77) | 62 (42–70) | 0.15 |
Side effects | |||
Percentage of pruritus requiring treatment | Overall: 50% | Overall: 70% | 0.11 |
Postanesthesia care unit: 33% | Postanesthesia care unit: 47% | 0.35 | |
Postpartum unit: 40% | Postpartum unit: 57% | 0.17 | |
Percentage of nausea requiring treatment | Overall: 53% | Overall: 60% | 0.60 |
Postanesthesia care unit: 33% | Postanesthesia care unit: 23% | 0.33 | |
Postpartum unit: 37% | Postpartum unit: 50% | 0.33 |
Mean ± SD were used for normally distributed variables; median (interquartile range) were used for data that were not normally distributed or for data with outliers or ordinal data; and number (percentage) were used for categorical data.
IQR = interquartile range.
Visual analog scale of pain using a 100 mm unmarked line.
Primary outcome; data are expressed as mean ± SD or median (interquartile range).